Inmazeb® (atoltivimab, maftivimab, and odesivimab-ebgn) was the first treatment approved by the U.S. Food and Drug Administration (FDA) for Orthoebolavirus zairense,…
Industry veterans Mark Bethke and Amit Mehta join firm to strengthen value-based care and population health services MCLEAN, Va., Sept.…
Dr. Duncan's appointment to this prestigious role recognizes his extraordinary contributions to the actuarial profession and healthcare innovation over three…
New Identity Positions Organization to Lead the Future of Proactive, Technology-Enabled Care PHILADELPHIA, Sept. 17, 2025 /PRNewswire/ -- The Medical…
NEW YORK, Sept. 17, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global digital…
FOP is a disease in which muscles, tendons and ligaments are progressively replaced by bone, leading to eventual incapacitation Garetosmab…
Healthcare leaders are rethinking tech investments to safeguard revenue, improve efficiency, and ensure compliance amid reimbursement and interoperability uncertainty PITTSBURGH,…
This partnership enables nationwide access to InTandem® for adults with chronic stroke and MOVIVE™ for people with Parkinson's disease (PD) PORTLAND, Maine,…
Population health management for health plans and pharmacy benefit managers enhanced by NCQA HEDIS-certified CareProminence 360Measures™ technology TAMPA, Fla., Sept.…
Black Book survey: IT modernization is the lever to keep home health nurses and protect access as Medicare rate changes…